Recalls / Active ingredient / Sodium Salicylate
Sodium Salicylate
1 FDA drug recall involving the active ingredient “Sodium Salicylate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-01-24 | Class II | Cystex Urinary Pan Relief (NSAID) (methenamine 162mg, sodium salicylate 162.5mg tablets) packaged in a) 40-cou | Ultra Seal Corporation |